Cardiology Update 2011 Davos February 2011
|
|
- Kathlyn Fleming
- 5 years ago
- Views:
Transcription
1 Cardiology Update 211 Davos February 211 Improvement of Risk Prediction for Coronary Events using Signs of Subclinical Atherosclerosis and Biomarkers Raimund Erbel Department of Cardiology West-German Heart Center University Duisburg-Essen
2 Improvement of Risk Prediction for Coronary Events using Signs of Subclinical Atherosclerosis and Biomarkers Proportion of in-hospital CHD Death Proportion of CHD deaths (%) within 28 days occurring in hospital by sex, age, and calendar year, 1991 to 26. Women Men Kerstin Dudas et. al. Circulation 123:46-52, /211 Leszek K Borysiewicz
3 Improvement of Risk Prediction for Coronary Events using Signs of Subclinical Atherosclerosis and Biomarkers Most Deaths of AMI occur out of the hospital Mortality due to CHD in the hospital (within 28 days) and out of the hospital per 1 population years of age, 1991 to 26. Kerstin Dudas et. al. Circulation 123:46-52, /211
4 1.Step: Score based Risk Stratification A. Framingham Assmann et al. Circulation 15:31-315, 22 B. PROCAM JAMA 385, 21 Graham I et al EJCPR 14 (suppl 2:S1-113), 27
5 2. Step based Risk Categorization Low risk Intermediate risk < 1% / 1 years 1 2% / 1 years advice for healthy lifestyle - detection of signs of subclinical atherosclerosis High risk = equivalent to post AMI > 2% / 1 years intensive therapy / risk factor modification + Greenland et al. Circulation 2;11: Greenland et al. Circulation 21;14: NCEP / ATP III JAMA 21;285: # Erbel et al. Atherosclerosis 27;197:662-72
6 Observed 5-yr Event Rate [%] 2. Step: Risk Prediction for Coronary Events using Framingham Risk Score in HNR study Events / # at Risk: Relative Risk: / / ( ) p=.3 29 / ( ) 12 p= % % 2.8 % Low Intermediate High Framingham Risk Score Erbel R et. al. JACC 56: , 21
7 3. Step: subclinical signs of atherosclerosis used for further risk stratification Prevalence of risk categories in Germany for healthy lifestyle Low Risk Men / Women 3% / 71% < 1% / 1 years - Imaging techniques Intermediate Risk 39% / 2% 1 2% / 1 years Non imaging techniques Stress ECG (M 45-6 J) Biomarker High Risk 31% / 9% > 2% / 1 years + Data from the Heinz Nixdorf Recall Study# (incl. ATP III risk equivalents*) intensive therapy / risk factor modification Greenland et al. Circulation 2;11: Greenland et al. Circulation 21;14: NCEP / ATP III JAMA 21;285: # Erbel et al. Atherosclerosis 27;197:662-72
8 Di82 Imaging of Coronary Subclinical Atherosclerosis Non invasive Methods MRT CT/CTA Vasomotion testing PET EKG ECHOCARDIOGRAPHY SCINTIGRAPHY Invasive Methods OCT IVUS/ICD IRS CORONARY ANGIOGRAPHY % 2% 45% 5% 7% 9% Remodeling Life time modified according to Erbel R et al HERZ 32:351-55, 27 originally ERBEL R HERZ 21: 75-77, 1996
9 Non-Invasive Imaging of Subclinical Coronary Atherosclerosis using Computed Tomography No CAC 56 year M Ao LM RVOT LAD Score 49 CAC 51 year M Score Score year F 5 year M Detection - Distribution Quantification
10 Non-Invasive Imaging of Subclinical Coronary Atherosclerosis using Computed Tomography - < 2 s scan time msv X-ray exposure - 1 ms acquisition time - standardized protocols: Agatston-Score Imaging of coronary artery calcification as a specific sign of atherosclerosis min total time -.94 Kappa value for interinstitutional variation Agatston et al. JACC 15:827-32, 199 Hunold P et al Radiology 226:14552,23 Schmermund et al. Z Kardiol 92:I/385,23
11 Observed 5-yr Event Rate [%] 3. Step: Improving Risk Prediction for Coronary Events using Signs of Coronary Subclinical Atherosclerosis by CT Events / # at Risk: Crude Relative Risk: FRS-adjusted* RR: / p= / ( ) 1.46 (.71-3.) p=.2 23 / ( ) 3.6 ( ) p=.7 33 / ( ) 6.25 ( ) 8.3 % 4.9 % 1.5 % 3.5 % < CAC Scoring Erbel R et. al. JACC 56: , 21
12 Improvement of Risk Prediction for Coronary Events using Signs of Coronary Subclinical Atherosclerosis by CT categories Meta-analysis HNR study Meta-analysis HNR study Meta-analysis HNR study Meta-analysis HNR study Greenland et al. ACCF/AHA 27 Clinical expert consensus document JACC 115:42, 27 Erbel et al JACC 56: , 21
13 Improvement of Risk Prediction for Coronary Events using Signs of Coronary Subclinical Atherosclerosis by CT Rotterdam Study Elias-Smale SE et al JACC 56:147-14, 21
14 Improvement of Risk Prediction for Coronary Events using Signs of Subclinical Atherosclerosis by CT demonstrated by the Net Reclassification Improvement NRI NRI: 2.8% (p=.4) low intermediate high Erbel R et. al. JACC 56: , 21
15 Improvement of Risk Prediction for Coronary Events using Signs of Subclinical Atherosclerosis by CT demonstrated by the Net Reclassification Improvement NRI Classification according to FRS Reclassification accounting for CAC scores Low Intermed. High Total Coronary events <1% 1-2% >2% Total Number No coronary events <1% 1-2% >2% Total NRI: 2.8% (p=.4) Erbel R et. al. JACC 56: , 21
16 Improvement of Risk Prediction for Coronary Events using Signs of Subclinical Atherosclerosis by CT demonstrated by the Net Reclassification Improvement NRI Comparison to the FRS 6-2% instead of 1-2% Classification according to FRS 1-year event rate with events - low - intermediate - high Total without events - low - intermediate - high Total Reclassification accounting for CAC scores low intermed. high Total Erbel R et. al. JACC 56: , NRI = 3.6% (p<.1)
17 3. Step: Improving Risk Prediction for Coronary Events using Signs of Inflammation a Biomarker Prevalence of risk categories in Germany advice for for healthy lifestyle Low Risk Men / Women 3% / 71% < 1% / 1 years - Intermediate Risk 39% / 2% 1 2% / 1 years Detection of signs of risk for CV events Biomarker High Risk 31% / 9% > 2% / 1 years + Data from the Heinz Nixdorf Recall Study# (incl. ATP III risk equivalents*) intensive therapy / risk factor modification Greenland et al. Circulation 2;11: Greenland et al. Circulation 21;14: NCEP / ATP III JAMA 21;285: # Erbel et al. Atherosclerosis 27;197:662-72
18 Improvement of Risk Prediction for Coronary Events using Biomarkers Lipoprotein (a) Homocystein Cholesterol (TC) LDL-Cholesterol (LDLC) Univariate Analysis for cardiac deah, AMI, revascularisation n = * n = TC/HDLC-Ratio HS-CRP Calcium Score * Relative Risk of Future Cardiovascular Events Ridker PM et al Circulation 13: 1813, 21 *O Malley PG et al Am J Cardiol 85: 945, 21
19 Observed 5-yr Event Rate [%] 3. Step: Improving Risk Prediction for Coronary Events using the Biomarker hs-crp Events / # at Risk: Crude Relative Risk: FRS-adjusted* RR: 2 23 / / ( ).93 ( ) 37 / ( ) 1.87 ( ) 16 p= Möhlenkamp S et al p= % 1.7 % 1.8 % <1. mg/l 1-3 mg/l >3 mg/l hscrp Categories JACC 211 in press
20 Improvement of Risk Prediction for Coronary Events using the Biomarker hs-crp vs CAC mg/l hs-crp Möhlenkamp S et al JACC 211 in press
21 Sensitivity Improvement of Risk Prediction for Coronary Events using the Biomarker hs-crp vs CAC FRS only:.691 ( ) FRS+hsCRP:.74 ( ) FRS+log 2 (CAC+1):.752 (.7-.84) FRS+hsCRP+log 2 (CAC+1):.76 ( ) Specificity AuROC-Curve: p=.34 p=.74 p=.14 p=.19 Möhlenkamp S et al JACC 211 in press
22 Improvement of Risk Prediction for Coronary Events using the Biomarker hs-crp Net Reclassification Improvement Classification according to FRS Coronary events <1% 1-2% >2% Total Number No coronary events <1% 1-2% >2% Total Reclassification accounting for hscrp scores Low Intermed. High Total NRI: 7.8% (p=.14) Möhlenkamp S et al JACC 211 in press
23 Improvement of Risk Prediction for Coronary Events using Signs of Subclinical Atherosclerosis and Biomarkers Risk Marker / Factor: NRI p-value Reference Multiple Biomarker Score 26.7% p=.5 (Zethelius, NEJM 28)* (Troponin I, NT-proBNP, Cystatin C, CRP) Multiple Biomarker Score 14.6% p=ns (Melander, JAMA 29)* (MR-proADM, NT-proBNP) HDL-Cholesterol (Framingham) 12.1% p<.1 (Pencina, Stat Med 28) HDL-Cholesterol (SCORE-Data) 2.2% p=.6 (Cooney, EJCPR 29) hscrp (women) 5.7% p<.1 (Cook, Ann Int Med 26) hscrp (men and women) 11.8% p<.9 (Wilson Cirulation 28) hscrp (men) 14.1% p<.1 (Ridker, Circulation 28)* HbA1c (men) 3.4% p=.6 (Simmons, Arch Int Med 28) HbA1c (women) - 2.2% p=.27 (Simmons, Arch Int Med 28) CAC HNR(ATP III, FRS 1-2%, 6-1%) 18.8, 21.7%, 3.6% p=.2 (Erbel, JACC 21)* Rotterdam FRS 1 2 % 14% p<.1 also hard events,older MESA FRS 6 2% 3% p<.1 also soft endpoints modified from Cooney et al. JACC 54 : , 29 Erbel R et al JACC 56 : , 21
24 Improvement of Risk Prediction for Coronary Events using Signs of Subclinical Atherosclerosis and Biomarkers Risk Marker / Factor: NRI p-value Reference Multiple Biomarker Score 26.7% p=.5 (Zethelius, NEJM 28)* (Troponin I, NT-proBNP, Cystatin C, CRP) Multiple Biomarker Score 14.6% p=ns (Melander, JAMA 29)* (MR-proADM, NT-proBNP) HDL-Cholesterol (Framingham) 12.1% p<.1 (Pencina, Stat Med 28) HDL-Cholesterol (SCORE-Data) 2.2% p=.6 (Cooney, EJCPR 29) Heart Rate 1.1% p=ns (Cooney, ESC 29, Abstract) hscrp (women) 5.7% p<.1 (Cook, Ann Int Med 26) hscrp (men and women) 11.8% p<.9 (Wilson Cirulation 28) hscrp (men) 14.1% p<.1 (Ridker, Circulation 28)* hscrp (total 7.8% p <.14 (Möhlenkamp JACC 211) HbA1c (men) 3.4% p=.6 (Simmons, Arch Int Med 28) HbA1c (women) - 2.2% p=.27 (Simmons, Arch Int Med 28) CAC (ATP III, FRS 1-2%, 6-1%) 18.8, 21.7%, 3.6% p=.2 (Erbel JACC 21)* modified from Cooney et al. JACC 54 : , 29 Erbel R et al JACC 56 : , 21
25
26 I dedicate my lecture to Philip Poole-Wilson and Helmut Drexler
27 Improvement of Risk Prediction for Coronary Events using Signs of Subclinical Atherosclerosis and Biomarkers Conclusion In comparison to other signs of subclincial atherosclerosis CAC seems to be the method of choice for improvement of risk prediction. And cardiology has to turn its attention to prevention, because here the biggest target for risk improvement has to be recognized as the majority of patient (6 to 8 %), who die from AMI, die outside the hospital and do not reach the hospital.
28
29 Background for Improving Risk Prediction Acute onset of coronary syndromes still combined with - up to 5 % rate of sudden deaths Fox CS et al Circulation 11: 522-7, 24 AHA: Heart Disease and Stroke Update 29 at a glance - 6 % of deaths outside the hospital with no improvement over the last 1 years (MONICA/KORA) Löwel H et al Dtsch Ärztebl 13:A616-22, 26 - prevention at top of list of measures to reduce case fatality from CAD Chambless et al (MONICA study) Circulation 96: ,1997
30 Aim of the Study Heinz Nixdorf Recall Study (HNR) Risk Factors, Evaluation of Coronary Calcium and Lifestyle coronary calcium as a sign of subclinical coronary atherosclerosis improves risk prediction for cardiovascular events in comparison to risk factors Initiated in 1999 and started in 2 Funded by the Heinz Nixdorf Foundation (chairman: G Schmidţ) International Advisory Board: Th Meinertz, (chair) supported by German Foundation of Research Erbel et al In: Late breaking clinical trial, ACC 29
31 Methods I of the Heinz Nixdorf Recall Study - prospective, population-based cohort study according to GEP - random samples from resident registration offices men and women, aged years (response: 56%) between 12/2 and 6/23 - urban population with 1.5 million inhabitants in an big city area of 8 million people - study certified and recertified according to ISO 91:2 Schmermund A et al Am Heart J 144:212-18, 22 Stang A et al Eur J Epidemiol 2: , 25 Dragano N et al Eur J Cardvasc Prev Rehab 14:568-74, 27
32 Mason Sones in Frankfurt we are still living in a world where almost 1/3 of the patients who die... die suddenly before we were even aware that these people were ill or that their lives were in jeopardy. So it seems to me that the most important problem we face is to find a way of recognizing these people before they drop dead and tell us that they were sick In: Coronary Heart Disease, 3rd Int. Symposium Frankfurt, Kaltenbach M, Lichtlen P, Balcon R, Bussmann WD (eds) Thieme, Stuttgart 1978; 83
33 1-sensitivity Improvement of Risk Prediction for Coronary Events using Signs of Subclinical Atherosclerosis by CT MESA-Study: - population-based vs 4814 subjects - age: vs years - 6 vs 3 cities - 4 vs 1 ethnic groups - no CVD at entry - follow-up: 3.5 vs 5 years CAC+FRS AuROC=.83 CAC alone AuROC=.78 (p=.6 vs. CAC+FRS) FRS alone AuROC=.79 (p=.1 vs. CAC+FRS) HNR.749** HNR.741* HNR.681 Comparison of MESA and HNR not randomly vs randomly selected CAC burden known versus unknown results!! ΔAuROC.51 vs.68 * p=.46, ** p=.3 Detrano et al NEJM 28 Erbel et al JACC 56: , 21
34 Improvement of Risk Prediction for Coronary Events using Signs of Subclinical Atherosclerosis by CT Combined End-points Hard Events HNR.749** calcium score better than percentile cut-off values like 75th percentile Budoff M et al J Am Coll Cardiol 53:345-52, 29 Brown ER et al Radiology 247:669-75, 28 Erbel et al JACC 56: , 21
35 Improvement of Risk Prediction for Coronary Events using Signs of Subclinical Atherosclerosis and Biomarkers Helmut Drexler died 6 months later with 58 years Philip Alexander Poole-Wilson death with 66 years March 4, 29 Two weeks after last Update in Cardiology In Davos
36 Methods II: for detection of Subclinical atherosclerosis - Framingham Risk Score - electron beam CT (GE-Imatron, San Francisco), - for coronary artery calcification scoring (Agatston score) - carotid ultrasound for measuring intimal media thickness and plaques - blood pressure at ankle and arm for ankle-arm index (ABI) measurement Stang A et al Am J Epidemiol 164:85-94, 26 Erbel R et al Atherosclerosis 197:662-72, 28 Schmermund A et Atherosclerosis 185:177-82, 26 Greenland P et al Circulation 115:42-26, 27
37 Erbel et al., (eingereicht) RR für CAC und hscrp
38 Endotheliale Dysfunktion Herrmann J, Lerman A Herz 27 in press
39 Atherosklerose Pathogenese Herrmann J, Lerman A Herz 27 in press 39
40 Atherosklerose: Gefaesswand als Target Herrmann J, Lerman A Herz 27 in press
41 Atherosklerose Pathogenese Herrmann J, Lerman A Herz 27 in press
42 HeartScore Classification
43 Risikofaktoren der Atherosklerose (Hypertonie, Dyslipidämia, Diabetes. Rauchen, Adipositas, Alter, Geschlecht Mentaler Stress, chronischeentzündung) Endotheliale Dysfunktion EPCs (Zahlreduktion, Funktionsstörung) 1. Gestörte Regulation des vaskulären Tonus und Struktur 2. Gesteigerte vaskuläre Inflammation Entwicklung und Progression der Atherosklerose 3.Prothrombotische Phänotyp Änderung des Endothels 4. Gestörte endogene endotheliale Reparation Giannotti/Landmesser Herz 32:568-72, 27
44 % Participants Non-Invasive Imaging of Subclinical Coronary Atherosclerosis using Computed Tomography Männer Male Frauen Female Prevalence of CAC 82 % Men 55 % Women >= 1 Schmermund et al Atherosclerosis 26
45 Agatston CAC Score Agatston CAC Score Non-Invasive Imaging of Subclinical Coronary Atherosclerosis using Computed Tomography 5th CAC-Percentile 9th CAC-Percentile MESA HNR 25 2 MESA HNR Age/years Age/years MESA multiethnic study of atherosclerosis McClelland et al. Circulation 26 Schmermund et al Atherosclerosis 26
46 CAC Agatston Score Unit Non-Invasive Imaging of Subclinical Coronary Atherosclerosis using Computed Tomography smoking and coronary artery calcification no smoking 3 cigaretts/die, stop 2 years ago 3 cigaretts/die Current Smoking Former smoking nosmoking Age/years Jöckel et al Atherosclerosis 28 46
47 Veränderung des Kalkscore [%] Change of CAC/ % Non-Invasive Imaging of Subclinical Coronary Atherosclerosis using Computed Tomography 3 25 pollution and coronary artery calcification adjusted analysis Distanz >2; PM<=22 (141) Distanz >2; PM>25 (84) Rest (3339) Distanz <=1; PM<=22 (33) Distanz <=1; PM>25 (38) adjusted for age, sex, education, smoking, hypertension, D.m., cholesterol, living area B Hoffmann et al Circulation116: , 27
48 Coronary artery calcification Agatston Score Unit Coronary artery calcification Agatston Score Unit Non-Invasive Imaging of Subclinical Coronary Atherosclerosis using Computed Tomography socio-economics and coronary artery calcification Men Women Income quartiles Income quartiles N Dragano et al Eur J Cardiovasc Prev Rehabil 14:
49 Net Reclassification Improvement by CAC in Comparison to the Framingham Risk Score Comparison to the FRS 6-2% instead of 1-2% Classification according to FRS 1-year event rate with events Reclassification accounting for CAC scores low intermed. high Total - low - intermediate - high Total without events - low - intermediate - high Total NRI = 3.6% (p<.1) Note: Folie 49 more correct Titel down- than up classification in those with events
Subclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD
Subclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD Sao Paulo Medical School Sao Paolo, Brazil Subclinical atherosclerosis in CVD risk: Stratification & management Prof.
More informationNew Paradigms in Predicting CVD Risk
New Paradigms in Predicting CVD Risk Imaging as an Integrator of Lifetime Risk Exposure Michael J. Blaha MD MPH Presented by: Michael J. Blaha September 24, 2014 1 Talk Outline Risk factors vs. Disease
More informationCoronary Artery Calcium. Vimal Ramjee, MD FACC The Chattanooga Heart Institute
Coronary Artery Calcium Vimal Ramjee, MD FACC The Chattanooga Heart Institute Disclosures I have no conflicts of interest to disclose. Objectives Recognize the utility of coronary artery calcium scoring
More informationCoronary Risk Stratification, Discrimination, and Reclassification Improvement Based on Quantification of Subclinical Coronary Atherosclerosis
Journal of the American College of Cardiology Vol. 56, No. 17, 2010 2010 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2010.06.030
More informationPotential recommendations for CT coronary angiography in athletes
Potential recommendations for CT coronary angiography in athletes B.K. Velthuis Dept. of Radiology UMC Utrecht, the Netherlands EuroPRevent 15 April 2011 Declaration of interest Philips Medical Systems
More informationCoronary Artery Calcification
Coronary Artery Calcification Julianna M. Czum, MD OBJECTIVES CORONARY ARTERY CALCIFICATION Julianna M. Czum, MD Dartmouth-Hitchcock Medical Center 1. To review the clinical significance of coronary heart
More informationFinancial Disclosures. Coronary Artery Calcification. Objectives. Coronary Artery Calcium 6/6/2018. Heart Disease Statistics At-a-Glace 2017
Coronary Artery Calcification Dharmendra A. Patel, MD MPH Director, Echocardiography Laboratory Associate Program Director Cardiovascular Disease Fellowship Program Erlanger Heart and Lung Institute UT
More informationCVD risk assessment using risk scores in primary and secondary prevention
CVD risk assessment using risk scores in primary and secondary prevention Raul D. Santos MD, PhD Heart Institute-InCor University of Sao Paulo Brazil Disclosure Honoraria for consulting and speaker activities
More informationCT Calcium Score and Statins in Primary CV Prevention. Dr Selwyn Wong
CT Calcium Score and Statins in Primary CV Prevention. Dr Selwyn Wong Promises, Pitfalls and Hard Truths of Coronary Calcium Scanning Selwyn Wong Ascot and Middlemore Hospitals Coronary Calcium Scoring
More informationMEDICAL POLICY SUBJECT: CORONARY CALCIUM SCORING
MEDICAL POLICY PAGE: 1 OF: 5 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical policy criteria are not applied.
More informationLearning Objectives. Predicting and Preventing Cardiovascular Disease. ACC/AHA Cholesterol Guidelines Key differences vs ATP III
Presenter Disclosure Information 10:30 11:15am Predicting and Preventing Cardiovascular Disease: Can we put the Cardiologist out of business? The following relationships exist related to this presentation:
More informationThe role of coronary artery calcium score on the detection of subclinical atherosclerosis in metabolic diseases
The role of coronary artery calcium score on the detection of subclinical atherosclerosis in metabolic diseases Eun-Jung Rhee Department of Endocrinology and Metabolis Kangbuk Samsung Hospital Sungkyunkwan
More informationAre We Ready for a Paradigm Shift From Risk Factors to Detection of Subclinical Coronary Atherosclerosis? Lessons From MESA. Khurram Nasir, MD MPH
Are We Ready for a Paradigm Shift From Risk Factors to Detection of Subclinical Coronary Atherosclerosis? Lessons From MESA Khurram Nasir, MD MPH Disclosures No disclosures. Burden of Cardiovascular Disease
More informationMOHAMMED R. ESSOP DIVISION OF CARDIOLOGY CH-BARAGWANATH HOSPITAL
MOHAMMED R. ESSOP DIVISION OF CARDIOLOGY CH-BARAGWANATH HOSPITAL DEFINITION OF A SCREENING TEST TESTING FOR A DISEASE OR CONDITION IN ASYMPTOMATIC PERSONS TO IDENTIFY THE CONDITION BEFORE IT MANIFESTS
More informationCVD Risk Assessment. Michal Vrablík Charles University, Prague Czech Republic
CVD Risk Assessment Michal Vrablík Charles University, Prague Czech Republic What is Risk? A cumulative probability of an event, usually expressed as percentage e.g.: 5 CV events in 00 pts = 5% risk This
More informationMEDICAL POLICY. 02/15/18 CATEGORY: Technology Assessment
MEDICAL POLICY SUBJECT: CORONARY CALCIUM SCORING PAGE: 1 OF: 5 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product, including
More informationCurrent and Future Imaging Trends in Risk Stratification for CAD
Current and Future Imaging Trends in Risk Stratification for CAD Brian P. Griffin, MD FACC Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic Disclosures: None Introduction
More informationTreatment of Cardiovascular Risk Factors. Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center
Treatment of Cardiovascular Risk Factors Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center Disclosures: None Objectives What do risk factors tell us What to check and when Does treatment
More informationDisclosures CORONARY CALCIUM SCORING REVISITED. Learning Objectives. Scoring Methods. Consultant for M2S, Inc. Coronary Calcium Scoring: Software
CORONARY CALCIUM SCORING REVISITED Disclosures Consultant for M2S, Inc. Julianna M. Czum, MD Director, Division of Cardiothoracic Imaging Department of Radiology Dartmouth Hitchcock Medical Center Assistant
More informationDiagnostic and Prognostic Value of Coronary Ca Score
Diagnostic and Prognostic Value of Coronary Ca Score Dr. Ghormallah Alzahrani Cardiac imaging division, Adult Cardiology department Prince Sultan Cardiac Center ( PSCC) Madina, June 2 Coronary Calcium
More informationMPS and Calcium Score in asymptomatic patient F. Mut, J. Vitola
MPS and Calcium Score in asymptomatic patient F. Mut, J. Vitola Nuclear Medicine Service, Asociacion Española Montevideo, Uruguay Quanta Diagnostico Nuclear Curitiba, Brazil Clinical history Male 63 y.o.,
More informationInflammation and and Heart Heart Disease in Women Inflammation and Heart Disease
Inflammation and Heart Disease in Women Inflammation and Heart Disease What is the link between een inflammation and atherosclerotic disease? What is the role of biomarkers in predicting cardiovascular
More informationEffective for dates of service on or after April 1, 2013, refer to:
Effective for dates of service on or after April 1, 2013, refer to: https://www.bcbsal.org/providers/policies/carecore.cfm Name of Policy: Computed Tomography to Detect Coronary Artery Calcification Policy
More informationAssessing atherosclerotic risk for long term preventive treatment
Assessing atherosclerotic risk for long term preventive treatment Donald A. Smith, MD, MPH Endocrinologist, Clinical Lipidologist Associate Professor of Medicine and Preventive Medicine Icahn School of
More informationUsing Coronary Artery Calcium Score in the Quest for Cardiac Health. Robert J. Hage, D.O.
Using Coronary Artery Calcium Score in the Quest for Cardiac Health Robert J. Hage, D.O. Heart disease is the leading cause of death in the United States in both men and women. About 610,000 people die
More informationPreclinical Detection of CAD: Is it worth the effort? Michael H. Crawford, MD
Preclinical Detection of CAD: Is it worth the effort? Michael H. Crawford, MD 1 Preclinical? No symptoms No physical findings No diagnostic ECG findings No chest X-ray X findings No diagnostic events 2
More informationCoronary Artery Calcium to Predict All-Cause Mortality in Elderly Men and Women
Journal of the American College of Cardiology Vol. 52, No. 1, 28 28 by the American College of Cardiology Foundation ISSN 735-197/8/$34. Published by Elsevier Inc. doi:1.116/j.jacc.28.4.4 CLINICAL RESEARCH
More informationThe role of coronary artery calcium score on the detection of subclinical atherosclerosis in metabolic diseases
The role of coronary artery calcium score on the detection of subclinical atherosclerosis in metabolic diseases Eun-Jung Rhee Department of Endocrinology and Metabolism Kangbuk Samsung Hospital Sungkyunkwan
More informationJohn J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam
Latest Insights from the JUPITER Study John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam Inflammation, hscrp, and Vascular Prevention
More informationImaging in the Evaluation of Coronary Artery Disease and Abdominal Aortic Aneurysm
Imaging in the Evaluation of Coronary Artery Disease and Abdominal Aortic Aneurysm Mark J. Sands, MD Vice Chairman, Imaging Institute Clinical Operations and Quality Objectives Review of available radiologic
More informationAssessing Cardiovascular Risk to Optimally Stratify Low- and Moderate- Risk Patients. Copyright. Not for Sale or Commercial Distribution
CLINICAL Viewpoint Assessing Cardiovascular Risk to Optimally Stratify Low- and Moderate- Risk Patients Copyright Not for Sale or Commercial Distribution By Ruth McPherson, MD, PhD, FRCPC Unauthorised
More informationCoronary Artery Calcium Scoring Mirvat Alasnag FACP, FRCP, FSCCT, FSCAI, FASE King Fahd Armed Forces Hospital, Jeddah. March 2017
Coronary Artery Calcium Scoring Mirvat Alasnag FACP, FRCP, FSCCT, FSCAI, FASE King Fahd Armed Forces Hospital, Jeddah March 2017 Newspapers Referrals 62 year old female CT chest and abdomen following
More informationJUPITER NEJM Poll. Panel Discussion: Literature that Should Have an Impact on our Practice: The JUPITER Study
Panel Discussion: Literature that Should Have an Impact on our Practice: The Study Kaiser COAST 11 th Annual Conference Maui, August 2009 Robert Blumberg, MD, FACC Ralph Brindis, MD, MPH, FACC Primary
More informationCardiac CT for Risk Assessment: Do we need to look beyond Coronary Artery Calcification
Cardiac CT for Risk Assessment: Do we need to look beyond Coronary Artery Calcification Matthew Budoff, MD, FACC, FAHA Professor of Medicine Director, Cardiac CT Harbor-UCLA Medical Center, Torrance, CA
More informationGuideline for Assessment of Cardiovascular Risk in Asymptomatic Adults. Learn and Live SM. ACCF/AHA Pocket Guideline
Learn and Live SM ACCF/AHA Pocket Guideline Based on the 2010 ACCF/AHA Guideline Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults November 2010 Guideline for Assessment of Cardiovascular
More informationCardiovascular Risk Panels. Summary
Subject: Cardiovascular Risk Panels Page: 1 of 8 Last Review Status/Date: March 2015 Cardiovascular Risk Panels Summary Cardiovascular risk panels refer to different combinations of cardiac markers that
More informationAortic Root Calcification: A Possible Imaging Biomarker of Coronary Atherosclerosis
Published online: January 8, 216 216 S. Karger AG, Basel 2235 8676/16/34 167$39.5/ Mini-Review Aortic Root Calcification: A Possible Imaging Biomarker of Coronary Hussein Nafakhi a Hasan A. Al-Nafakh b
More informationThe Multiethnic Study of Atherosclerosis (MESA) Cardiovascular Risk in Hispanics
The Multiethnic Study of Atherosclerosis (MESA) Cardiovascular Risk in Hispanics Michael H. Criqui MD, MPH Distinguished Professor and Chief, Division of Preventive Medicine Department of Family and Preventive
More informationKhurram Nasir, MD MPH
Non-invasive CAD Screening Khurram Nasir, MD MPH Disclosures I have no relevant commercial relationships to disclose, and my presentation will not include off label or unapproved usage. HOW & WHAT WOULD
More informationReview of guidelines for management of dyslipidemia in diabetic patients
2012 international Conference on Diabetes and metabolism (ICDM) Review of guidelines for management of dyslipidemia in diabetic patients Nan Hee Kim, MD, PhD Department of Internal Medicine, Korea University
More informationCLINICAL STUDY. Yasser Khalil, MD; Bertrand Mukete, MD; Michael J. Durkin, MD; June Coccia, MS, RVT; Martin E. Matsumura, MD
117 CLINICAL STUDY A Comparison of Assessment of Coronary Calcium vs Carotid Intima Media Thickness for Determination of Vascular Age and Adjustment of the Framingham Risk Score Yasser Khalil, MD; Bertrand
More informationCarotid Ddisease, Carotid IMT and Risk of Stroke
Carotid Ddisease, Carotid IMT and Risk of Stroke TATJANA RUNDEK, MD PhD Professor of Neurology, Epidemiology and Public Health Director, Clinical translational Division Department of Neurology, Miller
More informationIntima-Media Thickness
European Society of Cardiology Stockholm, 30th August 2010 Intima-Media Thickness Integration of arterial assessment into clinical practice Prof Arno Schmidt-Trucksäss, MD Institute of Exercise and Health
More informationCorporate Medical Policy
Corporate Medical Policy Computed Tomography to Detect Coronary Artery Calcification File Name: computed_tomography_to_detect_coronary_artery_calcification Origination: 3/1994 Last CAP Review 10/2017 Next
More informationCoronary Calcium Predicts Events Better With Absolute Calcium Scores Than Age-Sex-Race/Ethnicity Percentiles
Journal of the American College of Cardiology Vol. 53, No. 4, 2009 2009 by the American College of Cardiology Foundation ISSN 0735-1097/09/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2008.07.072
More informationMedical Policy. Medical Policy. MP Computed Tomography to Detect Coronary Artery Calcification
Medical Policy Medical Policy MP 6.01.03 BCBSA Ref. Policy: 6.01.03 Last Review: 09/28/2017 Effective Date: 09/28/2017 Section: Medicine Related Policies 6.01.43 Contrast-Enhanced Computed Tomography Angiography
More informationCRP for the Clinician
CRP for the Clinician J. C. Kaski, D.Sc., M.D., D.M (Hons), F.E.S.C., F.R.C.P., F.A.C.C. F.A.H.A Professor of Cardiovascular Science Head, Cardiovascular Sciences Research Centre St George s, University
More information1. Which one of the following patients does not need to be screened for hyperlipidemia:
Questions: 1. Which one of the following patients does not need to be screened for hyperlipidemia: a) Diabetes mellitus b) Hypertension c) Family history of premature coronary disease (first degree relatives:
More informationHow to Reduce Residual Risk in Primary Prevention
How to Reduce Residual Risk in Primary Prevention Helene Glassberg, MD Assistant Professor of Medicine Section of Cardiology Hospital of the University of Pennsylvania Philadelphia, PA USA Patients with
More informationAtherosclerotic Disease Risk Score
Atherosclerotic Disease Risk Score Kavita Sharma, MD, FACC Diplomate, American Board of Clinical Lipidology Director of Prevention, Cardiac Rehabilitation and the Lipid Management Clinics September 16,
More informationImaging-Guided Statin Allocation: Seeing Is Believing
Imaging-Guided Statin Allocation: Seeing Is Believing The New Paradigm in Personalized Risk Assessment & Medication Prescribing Presented by: Michael J. Blaha May 15, 2014 1 General Principles of Talk
More informationThe Framingham Risk Score (FRS) is widely recommended
C-Reactive Protein Modulates Risk Prediction Based on the Framingham Score Implications for Future Risk Assessment: Results From a Large Cohort Study in Southern Germany Wolfgang Koenig, MD; Hannelore
More informationAmerican Osteopathic College of Occupational and Preventive Medicine 2012 Mid-Year Educational Conference St. Petersburg, Florida
The 21 st Century Paradigm Shift: Prevention Rather Than Intervention for the Treatment of Stable CHD The Economic Burden of Cardiovascular Diseases Basil Margolis MD, FACC, FRCP Director, Preventive Cardiology
More informationPrevention of Heart Disease: The New Guidelines
Prevention of Heart Disease: The New Guidelines Nisha I. Parikh MD MPH Assistant Professor of Medicine Division of Cardiology Department of Medicine University of California San Francisco May 18 th 2015
More informationDyslipidemia in the light of Current Guidelines - Do we change our Practice?
Dyslipidemia in the light of Current Guidelines - Do we change our Practice? Dato Dr. David Chew Soon Ping Senior Consultant Cardiologist Institut Jantung Negara Atherosclerotic Cardiovascular Disease
More informationRisk Assessment for Primary Prevention
Risk Assessment for Primary Prevention AKA Some of You Won t Get a Second Chance to Make a First Impression Alternative Title: The Tension Between Population Medicine and Personalized Medicine Joshua Liberman,
More informationDyslipidemia in women: Who should be treated and how?
Dyslipidemia in women: Who should be treated and how? Lale Tokgozoglu, MD, FACC, FESC Professor of Cardiology Hacettepe University Faculty of Medicine Ankara, Turkey. Cause of Death in Women: European
More informationVascular calcification in patients with Diabetes Mellitus. Dr Jamie Bellinge University of Western Australia Royal Perth Hospital
Vascular calcification in patients with Diabetes Mellitus Dr Jamie Bellinge University of Western Australia Royal Perth Hospital Risk of cardiovascular disease Cardiovascular disease; - Stroke - Coronary
More informationWho Cares About the Past?
Risk Factors, the New Calcium Score, Rheology and Atherosclerosis Progression Arthur Agatston 2/21/15 The Vulnerable Plaque vs. Plaque Burden CT Angiogram Is There a Role for Coronary Artery Calcium Scoring
More informationVascular disease. Structural evaluation of vascular disease. Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital
Vascular disease. Structural evaluation of vascular disease Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital resistance vessels : arteries
More informationScreening for Cardiovascular Risk (2/6/09)
Screening for Cardiovascular Risk (2/6/09) Andrew Nicolaides MS, FRCS, FRCSE, PhD (Hon) Emeritus Professor of Vascular Surgery, Imperial College, London, UK Chairman, Cardiovascular Disease Educational
More informationCVD risk estimation in populations with high prevalence of MetS. Dilek Ural, 12 March 2017 Koç University, Istanbul
CVD risk estimation in populations with high prevalence of MetS Dilek Ural, 12 March 2017 Koç University, Istanbul Understanding CV risk Likelihood of a person developing an atherosclerotic CV event over
More informationCoronary Artery Calcium: Absence Makes the Heart Younger?
Coronary Artery Calcium: Absence Makes the Heart Younger? Parag H. Joshi, MD, MHS, FACC Assistant Professor of Medicine Division of Cardiology University of Texas Southwestern Medical Center Department
More informationCardiac CT Angiography
Cardiac CT Angiography Dr James Chafey, Radiologist Why do we need a better test for C.A.D? 1. CAD is the leading cause of death in the US CAD 31% Cancer 23% Stroke 7% 2. The prevalence of atherosclerosis
More informationComputed Tomography to Detect Coronary Artery Calcification. Original Policy Date
MP 6.01.02 Computed Tomography to Detect Coronary Artery Calcification Medical Policy Section Radiology Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date Reviewed with literature search/12:2013
More informationCORONARY ARTERY CALCIUM AND INCIDENT STROKE IN THE MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA) COHORT ASHLEIGH A. OWEN, MD
CORONARY ARTERY CALCIUM AND INCIDENT STROKE IN THE MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA) COHORT BY ASHLEIGH A. OWEN, MD A Thesis Submitted to the Graduate Faculty of WAKE FOREST UNIVERSITY GRADUATE
More informationBiomarkers in Cardiovascular Diseases. Peter Ganz, MD. Chief, Division of Cardiology, San Francisco General Hospital
Biomarkers in Cardiovascular Diseases Peter Ganz, MD Chief, Division of Cardiology, San Francisco General Hospital Maurice Eliaser Jr. Distinguished Professor of Medicine, University of California, San
More informationMedical Policy An Independent Licensee of the Blue Cross and Blue Shield Association
Computed Tomography to Detect Coronary Artery Calcification Page 1 of 9 Medical Policy An Independent Licensee of the Blue Cross and Blue Shield Association Title: See also: Computed Tomography (CT) to
More informationCurrent Cholesterol Guidelines and Treatment of Residual Risk COPYRIGHT. J. Peter Oettgen, MD
Current Cholesterol Guidelines and Treatment of Residual Risk J. Peter Oettgen, MD Associate Professor of Medicine Harvard Medical School Director, Preventive Cardiology Beth Israel Deaconess Medical Center
More informationSection: Radiology Last Reviewed Date: December Policy No: 6 Effective Date: February 1, 2014
Medical Policy Manual Topic: Computed Tomography to Detect Coronary Artery Calcification Date of Origin: January 1996 Section: Radiology Last Reviewed Date: December 2013 Policy No: 6 Effective Date: February
More informationHow would you manage Ms. Gold
How would you manage Ms. Gold 32 yo Asian woman with dyslipidemia Current medications: Simvastatin 20mg QD Most recent lipid profile: TC = 246, TG = 100, LDL = 176, HDL = 50 What about Mr. Williams? 56
More information10/8/2015. MN Nursing Conference October 7th, 2015 Michael Miedema, MD MPH. None
MN Nursing Conference October 7th, 2015 Michael Miedema, MD MPH None 1 Objectives Why the need for change in the guidelines? What is the potential impact of these guidelines? Where do we go from here?
More informationBiomarkers in risk prediction of heart and kidney disease
Biomarkers in risk prediction of heart and kidney disease Winfried März Medizinische Universität Graz, Medizinische Klinik V Medizinische Fakultät Mannheim, Universität Heidelberg, Synlab Akademie, Mannheim
More informationDisclosures. Prevention of Heart Disease: The New Guidelines. Summary of Talk. Four guidelines. No relevant disclosures.
Disclosures Prevention of Heart Disease: The New Guidelines No relevant disclosures Nisha I. Parikh MD MPH Assistant Professor of Medicine Division of Cardiology Department of Medicine University of California
More informationRole of imaging in risk assessment models: the example of CIMT
Role of imaging in risk assessment models: the example of CIMT Diederick E. Grobbee, MD, PhD, FESC Professor of Clinical Epidemiology Julius Center for Health Sciences and Primary Care, University Medical
More informationImproving Diagnostic, Prognostic & Therapeutic Biomarkers in Heart Disease. Professor Mark Richards Medicine, University of Otago, Christchurch
Improving Diagnostic, Prognostic & Therapeutic Biomarkers in Heart Disease Professor Mark Richards Medicine, University of Otago, Christchurch BNP / NT-ProBNP H 2 N 1 Pro-BNP Cardiomyocyte 76 77 108 COOH
More informationNew Guidelines in Dyslipidemia Management
The Fourth IAS-OSLA Course on Lipid Metabolism and Cardiovascular Risk Muscat, Oman, February 2018 New Guidelines in Dyslipidemia Management Dr. Khalid Al-Waili, MD, FRCPC, DABCL Senior Consultant Medical
More informationThe Art of Cardiovascular Risk Assessment
The Art of Cardiovascular Risk Assessment Laurence S. Sperling, M.D., FACC, FACP,FAHA, FASPC Professor of Medicine (Cardiology) Professor of Global Health Director- Center for Heart Disease Prevention
More informationCardiovascular risk assessment in patients with diabetes
DOI 10.1186/s13098-017-0225-1 Diabetology & Metabolic Syndrome REVIEW Open Access Cardiovascular risk assessment in patients with diabetes Marcello Casaccia Bertoluci 1,2,3* and Viviane Zorzanelli Rocha
More informationDescription. Section: Radiology Effective Date: October 15, 2015 Subsection: Radiology Original Policy Date: December 7, 2011 Subject:
Last Review Status/Date: September 2015 Page: 1 of 15 Description Background Coronary artery calcium (CAC) has been recognized to be associated with CAD on the basis of anatomic studies for decades. The
More informationBENEFIT APPLICATION BLUECARD/NATIONAL ACCOUNT ISSUES
Medical Policy Medical Policy MP 6.01.03 BCBSA Ref. Policy: 6.01.03 Last Review: 09/19/2018 Effective Date: 09/19/2018 Section: Medicine Related Policies 9.01.502 Experimental / Investigational Services
More informationLDL cholesterol (p = 0.40). However, higher levels of HDL cholesterol (> or =1.5 mmol/l [60 mg/dl]) were associated with less progression of CAC
Am J Cardiol (2004);94:729-32 Relation of degree of physical activity to coronary artery calcium score in asymptomatic individuals with multiple metabolic risk factors M. Y. Desai, et al. Ciccarone Preventive
More informationOptimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden
Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Cardiovascular Disease Prevention (CVD) Three Strategies for CVD
More informationSanger Heart & Vascular Institute Symposium 2015
Sanger Heart & Vascular Institute Symposium 2015 Cardiovascular Update For Primary Care Physicians William E. Downey, MD FACC FSCAI Medical Director, Interventional Cardiology Sanger Heart & Vascular Institute
More informationSetting The setting was the Walter Reed Army Medical Center. The economic study was carried out in the USA.
Coronary calcium independently predicts incident premature coronary heart disease over measured cardiovascular risk factors: mean three-year outcomes in the Prospective Army Coronary Calcium (PACC) project
More informationLatest Guidelines for Lipid Management
Latest Guidelines for Lipid Management Goals Recognize the differences between different guidelines Understand the effective strategies to tailor lipid lowering therapies based on evidence and guideline
More informationCase Presentation. Rafael Bitzur The Bert W Strassburger Lipid Center Sheba Medical Center Tel Hashomer
Case Presentation Rafael Bitzur The Bert W Strassburger Lipid Center Sheba Medical Center Tel Hashomer Case Presentation 50 YO man NSTEMI treated with PCI 1 month ago Medical History: Obesity: BMI 32,
More informationOptimal testing for coronary artery disease in symptomatic and asymptomatic patients
Optimal testing for coronary artery disease in symptomatic and asymptomatic patients Alexandre C Ferreira, MD Clinical Chief of Cardiology Jackson Health System Director, Interventional Cardiology Training
More informationPractical challenges in CV risk management: When to start intervening in CVD?
The National Research Center for Preventive Medicine Ministry of Healthcare, Russian Federation Practical challenges in CV risk management: When to start intervening in CVD? Prof. Drapkina O.M., Eliashevich
More informationShort and Long Term Prognosis after Coronary Artery Calcium Scoring
Short and Long Term Prognosis after Coronary Artery Calcium Scoring In Pre-Elderly and Elderly Patients Michael J. Blaha MD MPH Presented by: Michael J. Blaha July 24, 2017 1 Talk Outline 1. Coronary artery
More information2013 Lipid Guidelines Practical Approach. Edward Goldenberg, MD FACC,FACP, FNLA Medical Director of Cardiovascular Prevention CCHS
2013 Lipid Guidelines Practical Approach Edward Goldenberg, MD FACC,FACP, FNLA Medical Director of Cardiovascular Prevention CCHS EVIDENCE BASED MEDICINE Case #1 - LB 42 yo Asian/American female who was
More informationObjective Calcium score carotid IMT hs-crp
P3952 Role of coronary calcium score, carotid intima-media thickness and C-reactive protein in predicting extent of coronary artery disease in young patients. Bedside Poster P3952 Role of coronary calcium
More informationRenal Artery Calcification and Mortality Among Clinically Asymptomatic Adults
Journal of the American College of Cardiology Vol. 60, No. 12, 2012 2012 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.06.015
More informationCardiac Screening with Electrocardiography, Stress Echocardiography, or Myocardial Perfusion Imaging
Cardiac Screening with Electrocardiography, Stress Echocardiography, or Myocardial Perfusion Imaging A D V I C E F O R H I G H V A L U E C A R E F R O M T H E A M E R I C A N C O L L E G E O F P H Y S
More information2/9/2017. Financial Disclosures/Unapproved Use. Achieving Harmony in Blood Pressure Guidelines Around the Globe. Roger S. Blumenthal, MD.
Achieving Harmony in Blood Pressure Guidelines Around the Globe Roger S. Blumenthal, MD The Kenneth Jay Pollin Professor of Cardiology Director, The Johns Hopkins Ciccarone Center for the Prevention Of
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
Ultrasonographic Measurement of Carotid Intima-Medial Thickness Page 1 of 13 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Ultrasonographic Measurement of Carotid
More informationUltrasonographic Measurement of Carotid Intimal-Medial Thickness as an Assessment of Subclinical Atherosclerosis
Ultrasonographic Measurement of Carotid Intimal-Medial Thickness as an Assessment of Subclinical Atherosclerosis Policy Number: 2.02.16 Last Review: 10/2018 Origination: 4/2006 Next Review: 4/2019 Policy
More informationDavid Ramenofsky, MD Bryan Kestenbaum, MD
Association of Serum Phosphate Concentration with Vascular Calcification in Patients Free of Chronic Kidney Disease: The Multi Ethnic Study of Atherosclerosis David Ramenofsky, MD Bryan Kestenbaum, MD
More informationBeyond Framingham: Risk Assessment & Treatment for Primary Prevention
Beyond Framingham: Risk Assessment & Treatment for Primary Prevention Ronald M. Goldenberg, MD, FRCPC, FACE Consultant Endocrinologist, North York General Hospital Medical Co-Director, LMC Endocrinology
More informationEvidence-Based Management of CAD: Last Decade Trials and Updated Guidelines
Evidence-Based Management of CAD: Last Decade Trials and Updated Guidelines Enrico Ferrari, MD Cardiac Surgery Unit Cardiocentro Ticino Foundation Lugano, Switzerland Conflict of Interests No conflict
More information